Register

Inflammatory arthritis: Further reading and references

Rheumatoid arthritis

Reference	Summary
Arthritis Australia My RA Rheumatoid Arthritis Support Program	Information about rheumatoid arthritis (RA), tests and treatments, living with arthritis, managing pain and things you can do.
Australian Rheumatology Association Medication information	Information about medicines used to treat RA, including methotrexate, biological and targeted medicines.
Department of Health What are biosimilar medicines?	The Australian Government’s Biosimilar Awareness Initiative provides information about what biosimilar medicines are, including how they are tested and monitored.
An Australian Living Guideline for the Pharmacological management of Inflammatory Arthritis. 2020 [version 0.3].	The guideline presents the best available, current scientific evidence for the use of medicines to treat RA.
Smolen JS, Landewe RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 2020;79:685-99.	International recommendations for the management of RA with biological and targeted medicines.
Verhoef LM, van den Bemt BJ, van der Maas A, et al. Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity. Cochrane Database Syst Rev 2019;5:CD010455.	A summary of studies about the impact of reducing the dose of biological medicine for people with RA.
Wilsdon TD, Hill CL. Managing the drug treatment of rheumatoid arthritis. Aust Prescr 2017;40:51-8.	An overview of the medicines used to treat RA and the importance of early treatment.
van der Linden M, le Cessie S, Raza K, et al. Long-term impact of delay in assessment of patients with early arthritis,. Arthritis Rheum 2010;62(3537-46).	A study highlighting the importance of early treatment in RA.
Smolen JS, Gladman D, McNeil HP, et al. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study. RMD Open 2019;5:e000585.	A study exploring patients’ beliefs about medicines and other factors that affect whether people take medicine as directed.

Psoriatic arthritis

Reference	Summary
Arthritis Australia My PsA Psoriatic Arthritis Support Program	Information about psoriatic arthritis (PsA), tests and treatments, living with arthritis, managing pain and things you can do.
Australian Rheumatology Association Medication information	Information about medicines used to treat PsA, including methotrexate, biological and targeted medicines.
Psoriasis Australia	Information about psoriasis and PsA.
Department of Health What are biosimilar medicines?	The Australian Government’s Biosimilar Awareness Initiative provides information about what biosimilar medicines are, how they are tested and monitored,
An Australian Living Guideline for the Pharmacological management of Inflammatory Arthritis. 2020 [version 0.3].	The guideline presents the best available, current scientific evidence for the use of medicines to treat PsA.
Gossec L, Baraliakos X, Kerschbaumer A, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis 2020;79:700-12.	International recommendations for the management of PsA with medicines.
Smolen JS, Gladman D, McNeil HP, et al. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study. RMD Open 2019;5:e000585	A study exploring patients’ beliefs towards medicines and other factors that affect whether people take medicine as directed.

Ankylosing spondylitis (axial spondyloarthritis)

Reference	Summary
Arthritis Australia	Information about ankylosing spondylitis (AS), tests and treatments, living with arthritis, managing pain and things you can do.
Australian Rheumatology Association Medication information	Information about medicines used to treat AS, including methotrexate, biological and targeted medicines.
Department of Health What are biosimilar medicines?	The Australian Government’s Biosimilar Awareness Initiative provides information about what biosimilar medicines are, how they are tested and monitored,
An Australian Living Guideline for the Pharmacological management of Inflammatory Arthritis. 2020 [version 0.3].	The guideline presents the best available, current scientific evidence for the use of medicines to treat AS.
Van der Heijde D, Ramiro S, Landewe R et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 2017;76:978-991.	International recommendations for the management of AS.
Smolen JS, Gladman D, McNeil HP, et al. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study. RMD Open 2019;5(1):e000585.	A study exploring patients’ beliefs towards medicines and other factors that affect whether people take medicine as directed.